MET233

· Metsera (Pfizer subsidiary)

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MET233, covering 2026-02-03 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MET233 in Individuals With Obesity or Overweight [Phase 1, Phase 2]